Rights Issue Committee approves basis of allotment of ~83.64 lakh equity shares
Rights Issue Committee of Indrayani Biotech approved the basis of allotment of ~83.64 lakh Rights Equity Shares.
By ScoutQuest · · 2 min read
- Rights equity shares allotted
- ~83.64 lakh Rights Equity Shares
- Issue price
- ~75.03 lakh shares fully paid at Rs. 15 each (including premium of Rs. 5)
- Paid-up equity share capital
- rises from ₹ 45,53,62,560 to ₹ 53,25,47,648
What the update says
Indrayani Biotech's Rights Issue Committee met on November 03, 2026 and considered and approved the basis of allotment for ~83.64 lakh Rights Equity Shares of face value Rs. 10 each, issued on a rights basis to eligible equity shareholders and/or renouncers as per the Letter of Offer. The basis of allotment was finalised in consultation with BSE Limited, the designated stock exchange, which communicated its approval by email dated November 02, 2026. The exchange headline describes this as a revised outcome of the Committee meeting held on November 03, 2026.
How the issue was paid for
- ~75.03 lakh shares were fully paid at Rs. 15 each, including a premium of Rs. 5 per share.
- ~8.61 lakh shares were partly paid at Rs. 3.75 on application, including a premium of Rs. 1.25 per share. The balance amount is payable on the next call as defined in the Letter of Offer.
- The issue price of Rs. 15 per share is on a face value of Rs. 10, so Rs. 5 of it is premium.
What changed in the share capital
- Before the allotment: paid-up equity share capital of ₹ 45,53,62,560, comprising ~4.55 crore fully paid-up equity shares of Rs. 10 each.
- After the allotment: paid-up equity share capital of ₹ 53,25,47,648, comprising ~5.3 crore fully paid-up equity shares and ~8.61 lakh partly paid-up equity shares.
- In the capital figure, the partly paid shares are shown as Rs. 2.50 paid-up each, while the amount received on application was Rs. 3.75 per share.
What partly paid shares mean for a holder
A partly paid share means only part of the issue price has been paid so far. This is why the annexure says the balance is payable on the next call as defined in the Letter of Offer. A holder of these shares would need to pay the remaining amount when the company makes that call. Until then, these shares carry a lower paid-up value (Rs. 2.50) than the fully paid ones.
Points a retail investor may want to note
- The allotment adds equity shares to the company's capital: fully paid-up shares go from 4,55,36,256 to 5,30,39,589, plus ~8.61 lakh partly paid-up shares.
- The partly paid shares carry an obligation for further payment on the next call.
- The allotment was made to eligible equity shareholders and/or renouncers in terms of the Letter of Offer, and the basis of allotment was finalised in consultation with the designated stock exchange.
- The Committee meeting commenced at 4.30 pm and concluded at 5.30 pm.
Also from Indrayani Biotech
Rights Issue Committee approves basis of allotment for ~83.64 lakh partly paid-up shares
3 Nov 2026
Board to meet on 06 November 2026 to consider and approve draft notice of 34th AGM
3 Nov 2026
Secretarial Auditor appointed for FY 2025-26; Company Secretary & Compliance Officer resigns
2 Nov 2026
More numbers
- Rights Equity Shares allotted83,64,036
- Fully paid shares allotted at Rs. 15 each75,03,333 shares
- Partly paid shares allotted at Rs. 3.75 on application8,60,703 shares
- Issue price per fully paid share (incl. premium of Rs. 5)Rs. 15
- Amount paid on application per partly paid shareRs.3.75
- Paid-up equity share capital before allotment₹ 45,53,62,560
- Paid-up equity share capital after allotment₹ 53,25,47,648
- Fully paid-up equity shares after allotment5,30,39,589
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.